K2M Group Holdings, Inc. (KTWO) Stock Rating Reaffirmed by Oppenheimer Holdings, Inc.

Oppenheimer Holdings, Inc. reiterated their buy rating on shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) in a research report released on Thursday.

KTWO has been the subject of several other reports. TheStreet upgraded K2M Group Holdings from a d+ rating to a c rating in a research note on Monday, May 8th. Zacks Investment Research upgraded K2M Group Holdings from a sell rating to a hold rating in a research note on Tuesday, February 28th. Needham & Company LLC restated a buy rating and issued a $29.00 price objective on shares of K2M Group Holdings in a research note on Tuesday, March 7th. Royal Bank Of Canada restated a buy rating on shares of K2M Group Holdings in a research note on Wednesday, May 3rd. Finally, Cowen and Company restated an outperform rating and issued a $26.00 price objective (up from $21.00) on shares of K2M Group Holdings in a research note on Sunday, April 9th. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of $25.13.

K2M Group Holdings (KTWO) opened at 23.33 on Thursday. The company’s market capitalization is $992.83 million. K2M Group Holdings has a 52 week low of $14.49 and a 52 week high of $24.00. The company’s 50 day moving average price is $22.48 and its 200-day moving average price is $21.08.

K2M Group Holdings (NASDAQ:KTWO) last announced its quarterly earnings data on Tuesday, May 2nd. The medical device company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by $0.02. K2M Group Holdings had a negative return on equity of 16.02% and a negative net margin of 17.48%. The firm had revenue of $61.89 million during the quarter, compared to analysts’ expectations of $60.10 million. Equities research analysts expect that K2M Group Holdings will post ($0.80) earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This article was reported by BBNS and is the sole property of of BBNS. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://baseballnewssource.com/markets/k2m-group-holdings-inc-ktwo-stock-rating-reaffirmed-by-oppenheimer-holdings-inc/1098275.html.

In other K2M Group Holdings news, insider John Philip Md Kostuik sold 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $22.70, for a total value of $1,135,000.00. Following the sale, the insider now directly owns 199,107 shares of the company’s stock, valued at $4,519,728.90. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Gregory S. Cole sold 42,947 shares of the firm’s stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $22.80, for a total value of $979,191.60. Following the completion of the sale, the chief financial officer now directly owns 87,425 shares in the company, valued at $1,993,290. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 94,849 shares of company stock worth $2,155,454. 5.80% of the stock is owned by corporate insiders.

Hedge funds have recently modified their holdings of the stock. 1st Global Advisors Inc. raised its stake in shares of K2M Group Holdings by 2.9% in the first quarter. 1st Global Advisors Inc. now owns 13,101 shares of the medical device company’s stock valued at $269,000 after buying an additional 369 shares during the last quarter. Legal & General Group Plc raised its stake in shares of K2M Group Holdings by 9.1% in the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after buying an additional 564 shares during the last quarter. American International Group Inc. raised its stake in shares of K2M Group Holdings by 7.1% in the first quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock valued at $325,000 after buying an additional 1,047 shares during the last quarter. Teachers Advisors LLC raised its stake in shares of K2M Group Holdings by 3.0% in the first quarter. Teachers Advisors LLC now owns 43,823 shares of the medical device company’s stock valued at $899,000 after buying an additional 1,286 shares during the last quarter. Finally, Gabelli Funds LLC raised its stake in shares of K2M Group Holdings by 21.2% in the first quarter. Gabelli Funds LLC now owns 14,300 shares of the medical device company’s stock valued at $293,000 after buying an additional 2,500 shares during the last quarter. 98.82% of the stock is currently owned by institutional investors.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Miami Marlins Trade Adeiny Hechavarria to Tampa Bay
Miami Marlins Trade Adeiny Hechavarria to Tampa Bay
Baltimore Orioles Pitching Staff Continue to Fail
Baltimore Orioles Pitching Staff Continue to Fail
Cody Bellinger Continues Strong June at the Plate
Cody Bellinger Continues Strong June at the Plate
Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees


Leave a Reply

 
© 2006-2017 BBNS.